Carregant...
Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
BACKGROUND: Proprotein convertase subtilisin/kexin 9 (PCSK9) has been proposed as a novel target for coronary artery disease (CAD). Familial hypercholesterolemia (FH) is characterized by high prevalence of CAD and major cardiovascular events (MACEs). However, no data is available on the association...
Guardat en:
| Publicat a: | J Transl Med |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6849213/ https://ncbi.nlm.nih.gov/pubmed/31711505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-019-2123-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|